171 related articles for article (PubMed ID: 35713619)
1. Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis.
Carter SC; Franciosi AN; O'Shea KM; O'Carroll OM; Sharma A; Bell A; Keogan B; O'Reilly P; Coughlan S; Law SM; Gray RD; Hisert KB; Singh PK; Cooke G; Grogan B; De Gascun CF; Gallagher CG; Nicholson TT; Quon BS; McKone EF
Ann Am Thorac Soc; 2022 Nov; 19(11):1818-1826. PubMed ID: 35713619
[No Abstract] [Full Text] [Related]
2. Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.
Thornton CS; Caverly LJ; Kalikin LM; Carmody LA; McClellan S; LeBar W; Sanders DB; West NE; Goss CH; Flume PA; Heltshe SL; VanDevanter DR; LiPuma JJ
Ann Am Thorac Soc; 2024 Apr; 21(4):595-603. PubMed ID: 37963297
[No Abstract] [Full Text] [Related]
3. Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations.
Sharma A; Kirkpatrick G; Chen V; Skolnik K; Hollander Z; Wilcox P; Quon BS
PLoS One; 2017; 12(2):e0171229. PubMed ID: 28178305
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary exacerbation inflammatory phenotypes in adults with cystic fibrosis.
Dong K; Huh SM; Lam GY; Jang J; Franciosi AN; Wilcox PG; Quon BS
J Cyst Fibros; 2023 Mar; 22(2):306-312. PubMed ID: 36572614
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.
Sagel SD; Thompson V; Chmiel JF; Montgomery GS; Nasr SZ; Perkett E; Saavedra MT; Slovis B; Anthony MM; Emmett P; Heltshe SL
Ann Am Thorac Soc; 2015 May; 12(5):708-17. PubMed ID: 25714657
[TBL] [Abstract][Full Text] [Related]
6. Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
Davis CS; Faino AV; Onchiri F; Gibson RL; Merjaneh L; Ramsey BW; Rosenfeld M; Cogen JD
Ann Am Thorac Soc; 2023 Jan; 20(1):75-82. PubMed ID: 36044723
[No Abstract] [Full Text] [Related]
7. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
[TBL] [Abstract][Full Text] [Related]
8. SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis.
Ben-Meir E; Perrem L; Shaw M; Ratjen F; Grasemann H
J Cyst Fibros; 2024 Mar; 23(2):288-292. PubMed ID: 38413298
[TBL] [Abstract][Full Text] [Related]
9. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
[TBL] [Abstract][Full Text] [Related]
10. Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial.
Caceres SM; Sanders LA; Rysavy NM; Poch KR; Jones CR; Pickard K; Fingerlin TE; Marcus RA; Malcolm KC; Taylor-Cousar JL; Nichols DP; Nick JA; Strand M; Saavedra MT
PLoS One; 2022; 17(5):e0267592. PubMed ID: 35511761
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin, erythrocyte sedimentation rate and C-reactive protein in acute pulmonary exacerbations of cystic fibrosis.
Loh G; Ryaboy I; Skabelund A; French A
Clin Respir J; 2018 Apr; 12(4):1545-1549. PubMed ID: 28884501
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends.
Gifford AH; Polineni D; He J; D'Amico JL; Dorman DB; Williams MA; Nymon AB; Balwan A; Budden T; Zuckerman JB
Sci Rep; 2021 Mar; 11(1):4897. PubMed ID: 33649353
[TBL] [Abstract][Full Text] [Related]
13. Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations.
Jung D; Dong K; Jang J; Lam GY; Wilcox PG; Quon BS
J Cyst Fibros; 2021 Jan; 20(1):46-49. PubMed ID: 32475777
[TBL] [Abstract][Full Text] [Related]
14. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
[TBL] [Abstract][Full Text] [Related]
15. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
16. Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation.
Horsley AR; Davies JC; Gray RD; Macleod KA; Donovan J; Aziz ZA; Bell NJ; Rainer M; Mt-Isa S; Voase N; Dewar MH; Saunders C; Gibson JS; Parra-Leiton J; Larsen MD; Jeswiet S; Soussi S; Bakar Y; Meister MG; Tyler P; Doherty A; Hansell DM; Ashby D; Hyde SC; Gill DR; Greening AP; Porteous DJ; Innes JA; Boyd AC; Griesenbach U; Cunningham S; Alton EW
Thorax; 2013 Jun; 68(6):532-9. PubMed ID: 23396354
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis.
Sequeiros IM; Jarad N
Chron Respir Dis; 2012 Feb; 9(1):9-16. PubMed ID: 22308550
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic duration and changes in FEV
Espel JC; Palac HL; Cullina JF; Clarke AP; McColley SA; Prickett MH; Jain M
BMC Pulm Med; 2017 Nov; 17(1):160. PubMed ID: 29187171
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.
Hoppe JE; Wagner BD; Accurso FJ; Zemanick ET; Sagel SD
J Cyst Fibros; 2018 Nov; 17(6):760-768. PubMed ID: 29921503
[TBL] [Abstract][Full Text] [Related]
20. Treatment response to pulmonary exacerbation in primary ciliary dyskinesia.
Gatt D; Shaw M; Waters V; Kritzinger F; Solomon M; Dell S; Ratjen F
Pediatr Pulmonol; 2023 Oct; 58(10):2857-2864. PubMed ID: 37449771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
